azomycin has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalra, N; Malgaonkar, N; Nikhil, M; Pradeep, AR; Priyanka, N; Saquib, S; Tarakji, B; Umashree, D; Varsha, J | 1 |
| Komajda, M; Ruschitzka, F | 1 |
| Gao, F; Hu, M; Zheng, C | 1 |
| al-Arafaj, A; Hutchison, K; Mannan, RH; McEwan, AJ; Mercer, J; Ryan, EA; Wiebe, LI | 1 |
1 review(s) available for azomycin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
Topics: Aged; Animals; Antitubercular Agents; Arrhythmias, Cardiac; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diarylquinolines; Drug Interactions; Drug Monitoring; Humans; Hypoglycemic Agents; Middle Aged; Nitroimidazoles; Oxazoles; Polypharmacy; Risk Assessment; Risk Factors; Tuberculosis | 2016 |
1 trial(s) available for azomycin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Efficacy of Subgingivally Delivered Satranidazole in the Treatment of Type 2 Diabetes Subjects with Chronic Periodontitis: A Randomized Controlled Clinical Trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque Index; Dental Scaling; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Gels; Gingival Crevicular Fluid; Humans; Male; Middle Aged; Nitroimidazoles; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Root Planing; Treatment Outcome | 2015 |
2 other study(ies) available for azomycin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The year in cardiology 2015: heart failure.
Topics: Alcohol Drinking; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Chagas Cardiomyopathy; Chronic Disease; Diabetes Mellitus, Type 2; Genetic Therapy; Heart Failure; Humans; Hypoglycemic Agents; Nitroimidazoles; Respiration, Artificial; Risk Factors; Sleep Apnea, Central; Trypanocidal Agents | 2016 |
An evaluation of iodine-123 iodoazomycinarabinoside as a marker of localized tissue hypoxia in patients with diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Gas Monitoring, Transcutaneous; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Foot; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Nitroimidazoles; Peripheral Vascular Diseases; Radionuclide Imaging | 1994 |